MedTrace Logo

Impact of (Neo)Adjuvant Therapy Associating Anthracyclines and Taxanes With or Without Trastuzumab on Skeletal Muscle in Breast Cancer Patients

NCT04638712 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2023-02-09

No results posted yet for this study

Summary

This is an interventional, prospective and monocentric study. This study includes the evaluation before and after (neo)adjuvant therapy of :

* one group of patients receiving anthracyclines and taxanes
* a second group of patients receiving anthracyclines, taxanes and trastuzumab.

Conditions

Interventions

OTHER

Microbiopsy sample

before and after chemotherapy

OTHER

Muscle echography, Maximal strength, Body composition, Quality of life and Physical activity level

before and after chemotherapy

Sponsors & Collaborators

  • UR 3072 - Mitochondries, Stress oxydant, Protection musculaire

    collaborator UNKNOWN

  • Institut de cancérologie Strasbourg Europe

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-16
Primary Completion
2021-05-20
Completion
2021-05-20

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04638712 on ClinicalTrials.gov